Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Thera continues to post on cancer on Linkedin

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Sep 24, 2022 7:37am

143 Views

Post# 34983873

RE:RE:RE:RE:Thera continues to post on cancer on Linkedin

The timing for positive news in non economically sensitive stock could not be better....Greed does not go away when a recession looms...IF investors smell an opportunity to make profits money will flow recession or not.....THTX could be one of the rare stock attracting new money.... There are still a lot of IF s but any one IF will be beneficial to the SP .....
Increased sales , partner in Nash .partner in Oncology , positive clinical results in Phase 1 b ,
iF all the IF s were to come together in a relatively short period then maybe we all get rich but the odds of getting richer from here are very very high imo